PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics (NASDAQ: PTCT) has announced the approval of inducement grants for nine new employees on Sept. 8, 2024. The grants include 16,180 non-statutory stock options and 23,725 restricted stock units (RSUs). These awards are part of the new hires' compensation packages and comply with Nasdaq Listing Rule 5635(c)(4).
The stock options have an exercise price of $31.54 per share, based on the closing price on Sept. 6, 2024. They have a 10-year term and vest over four years, with 25% vesting on the first anniversary and 6.25% every three months thereafter. The RSUs also vest over four years, with 25% vesting annually. Both are subject to continued employment with PTC Therapeutics.
PTC Therapeutics (NASDAQ: PTCT) ha annunciato l'approvazione di concessioni di incentivazione per nove nuovi dipendenti l'8 settembre 2024. Le concessioni comprendono 16.180 opzioni di acquisto di azioni non statutarie e 23.725 unità di azioni vincolate (RSU). Questi premi fanno parte dei pacchetti retributivi dei nuovi assunti e sono conformi alla Regola 5635(c)(4) delle quotazioni Nasdaq.
Le opzioni di acquisto hanno un prezzo di esercizio di $31,54 per azione, basato sul prezzo di chiusura del 6 settembre 2024. Hanno un termine di 10 anni e maturano in quattro anni, con il 25% che matura al primo anniversario e il 6,25% ogni tre mesi successivamente. Anche le RSU maturing in quattro anni, con il 25% che matura annualmente. Entrambi sono soggetti a un'occupazione continuativa con PTC Therapeutics.
PTC Therapeutics (NASDAQ: PTCT) ha anunciado la aprobación de subvenciones por inducimiento para nueve nuevos empleados el 8 de septiembre de 2024. Las subvenciones incluyen 16,180 opciones de acciones no estatutarias y 23,725 unidades de acción restringida (RSUs). Estos premios son parte de los paquetes de compensación de los nuevos empleados y cumplen con la Regla de Cotización 5635(c)(4) de Nasdaq.
Las opciones de acciones tienen un precio de ejercicio de $31.54 por acción, basado en el precio de cierre del 6 de septiembre de 2024. Tienen un plazo de 10 años y se asignan en un período de cuatro años, con un 25% asignándose en el primer aniversario y un 6.25% cada tres meses a partir de entonces. Las RSUs también se asignan en un período de cuatro años, con un 25% asignándose anualmente. Ambos están sujetos a la continuidad del empleo con PTC Therapeutics.
PTC 치료제 (NASDAQ: PTCT)는 2024년 9월 8일에 9명의 신입 직원에 대한 유인 보조금 승인 소식을 전했습니다. 보조금에는 16,180개의 비지배적 주식 옵션과 23,725개의 제한 주식 유닛(RSU)이 포함됩니다. 이 상은 신입 직원들의 보상 패키지의 일환이며, Nasdaq 상장 규칙 5635(c)(4)를 준수합니다.
주식 옵션은 주당 $31.54의 행사 가격을 가집니다. 이는 2024년 9월 6일의 종가를 기준으로 합니다. 이들은 10년의 기간을 가지며 4년에 걸쳐 권리가 발생하며, 첫 번째 기념일에 25%가 발생하고 이후 매 3개월마다 6.25%가 발생합니다. RSU 또한 4년에 걸쳐 발생하며 매년 25%가 발생합니다. 두 가지 모두 PTC 치료제와의 지속적인 고용에 따라 달라집니다.
PTC Therapeutics (NASDAQ: PTCT) a annoncé le 8 septembre 2024 l'approbation de subventions d'incitation pour neuf nouveaux employés. Les subventions comprennent 16 180 options d'achat d'actions non statutaires et 23 725 unités d'actions restreintes (RSU). Ces récompenses font partie des packages de compensation des nouvelles recrues et sont conformes à la Règle de cotation 5635(c)(4) du Nasdaq.
Les options d'achat ont un prix d'exercice de 31,54 $ par action, basé sur le prix de clôture du 6 septembre 2024. Elles ont une durée de 10 ans et deviennent acquises sur quatre ans, avec 25 % acquises lors de la première date anniversaire et 6,25 % tous les trois mois par la suite. Les RSU deviennent également acquises sur quatre ans, avec 25 % acquises annuellement. Les deux sont soumis à une continuité d'emploi avec PTC Therapeutics.
PTC Therapeutics (NASDAQ: PTCT) hat am 8. September 2024 die Genehmigung für Anreizsubventionen für neun neue Mitarbeiter bekannt gegeben. Die Subventionen umfassen 16.180 nicht-statutory Aktienoptionen und 23.725 eingeschränkte Aktieneinheiten (RSUs). Diese Auszeichnungen sind Teil der Vergütungspakete der neuen Mitarbeiter und entsprechen der Nasdaq-Listing-Regel 5635(c)(4).
Die Aktienoptionen haben einen Ausübungspreis von $31,54 pro Aktie, basierend auf dem Schlusskurs vom 6. September 2024. Sie haben eine Laufzeit von 10 Jahren und werden über vier Jahre gewährt, wobei 25% am ersten Jahrestag und danach alle drei Monate 6,25% fällig werden. Auch die RSUs werden über vier Jahre gewährt, mit 25% jährlich. Beide sind an eine fortdauernde Beschäftigung bei PTC Therapeutics gebunden.
- Attraction of new talent with stock-based compensation
- Alignment of employee interests with company performance through equity grants
- Potential dilution of existing shareholders' equity
- Increased share-based compensation expenses
The inducement grants were approved by PTC's Compensation Committee on Sept. 8, 2024, and are being made as an inducement material to each employee's acceptance of employment with the company in accordance with Nasdaq Listing Rule 5635(c)(4).
All stock option awards have an exercise price of
ABOUT PTC THERAPEUTICS, INC.
PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to innovate to identify new therapies and to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines. PTC's mission is to provide access to best-in-class treatments for patients who have little to no treatment options. PTC's strategy is to leverage its strong scientific and clinical expertise and global commercial infrastructure to bring therapies to patients. PTC believes this allows it to maximize value for all its stakeholders. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Instagram, Facebook, Twitter, and LinkedIn.
For more information please contact:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com
View original content:https://www.prnewswire.com/news-releases/ptc-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-302247100.html
SOURCE PTC Therapeutics, Inc.
FAQ
How many new employees received inducement grants from PTC Therapeutics on Sept. 8, 2024?
What is the exercise price of the stock options granted by PTC Therapeutics (PTCT) in this announcement?
What is the vesting schedule for the RSUs granted by PTC Therapeutics (PTCT)?
How many stock options and RSUs did PTC Therapeutics (PTCT) grant in total?
